Solid forms of (R)-1(2,2difluorobenzo[d][1,3]dioxol-5-yl)-N-(1- (2,3-dihyderoxypropyl)-6-fluoro-2- (1hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide

Details for Australian Patent Application No. 2011230508 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Keshavarz-Shokri, Ali; Zhang, Beili; Alcacio, Tim Edward; Lee, Elaine Chungmin; Zhang, Yuegang; Krawiec, Mariusz

Agent Spruson & Ferguson

Pub. Number AU-A-2011230508

PCT Pub. Number WO2011/119984

Priority 61/317,376 25.03.10 US; 61/319,953 01.04.10 US; 61/321,636 07.04.10 US; 61/321,561 07.04.10 US

Filing date 25 March 2011

Wipo publication date 29 September 2011

International Classifications

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/404

A61P 11/00 Drugs for disorders of the respiratory system

Event Publications

18 October 2012 PCT application entered the National Phase

  PCT publication WO2011/119984 Priority application(s): WO2011/119984

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011230512-Methods of treatment of hepatocellular carcinoma

2011230503-Composite desiccant and air-to-water system and method